Sign In / Join

favorite Donate

close

person Sign In / Create Account

HealthTree News

HealthTree News is a place to learn all about your disease in easy-to-understand language. The site features news articles, patient stories, basics articles, and clinical trial updates with new content every week.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

FDA Approves New Treatment for R/R Acute Leukemia with KMT2A Translocation: Revumenib

Nov. 19, 2024

FDA Approves New Treatment for R/R Acute Leukemia with KMT2A Translocation: Revumenib

How to Truly Help Blood Cancer Caregivers and What to Possibly Avoid

Nov. 18, 2024

How to Truly Help Blood Cancer Caregivers and What to Possibly Avoid

Managing the Caregiver Roles: Chef, Chauffeur, Secretary, and More

Nov. 15, 2024

Managing the Caregiver Roles: Chef, Chauffeur, Secretary, and More

Flu and Covid-19 Vaccines: Should You Bundle Your Shots This Season?

Nov. 06, 2024

Flu and Covid-19 Vaccines: Should You Bundle Your Shots This Season?

Recruiting Trials for New Therapy Regimen for AML Patients

Oct. 29, 2024

Recruiting Trials for New Therapy Regimen for AML Patients

AML: Donor Age, Not Just a Number

Oct. 24, 2024

AML: Donor Age, Not Just a Number

Venetoclax + Decitabine Improve Senior AML Patients’ Chances of Receiving a Transplant

Oct. 22, 2024

Venetoclax + Decitabine Improve Senior AML Patients’ Chances of Receiving a Transplant

RVU120: A New Treatment in Clinical Trials for AML, MDS, and Myelofibrosis

Oct. 22, 2024

RVU120: A New Treatment in Clinical Trials for AML, MDS, and Myelofibrosis

James' Journey with AML: A Story of Resilience and Acceptance

Oct. 17, 2024

James' Journey with AML: A Story of Resilience and Acceptance

What are FLT3 Inhibitors, and How are They Used in AML?

Oct. 15, 2024

What are FLT3 Inhibitors, and How are They Used in AML?

What is Pancytopenia? Symptoms, Causes, & Treatments

Oct. 11, 2024

What is Pancytopenia? Symptoms, Causes, & Treatments

$CAR-T Therapy Trial for Relapsed/Refractory Acute Myeloid Leukemia$

Oct. 09, 2024

CAR-T Therapy Trial for Relapsed/Refractory Acute Myeloid Leukemia

Recent Articles

NPM1 Mutation in AML: Prognosis, Testing, & Treatments image

NPM1 Mutation in AML: Prognosis, Testing, & Treatments

October 04, 2024

What is the NPM1 mutation in acute myeloid leukemia (AML)? How common is it and how is it treated? Learn answers to these questions!

What are Clinical Trials, and How May They Help Me? image

What are Clinical Trials, and How May They Help Me?

September 30, 2024

Learn about clinical trials to open the door to accessing innovative cancer treatments.

The Future of Blood Cancer: Advances in Detection, Treatment, and Research image

The Future of Blood Cancer: Advances in Detection, Treatment, and Research

September 24, 2024

Explore the promising advancements in blood cancer detection, treatment, and research, shaping a brighter future for patients.

Treatment Advances

FDA Approves New Treatment for R/R Acute Leukemia with KMT2A Translocation: Revumenib image

FDA Approves New Treatment for R/R Acute Leukemia with KMT2A Translocation: Revumenib

AML: Donor Age, Not Just a Number image

AML: Donor Age, Not Just a Number

Venetoclax + Decitabine Improve Senior AML Patients’ Chances of Receiving a Transplant image

Venetoclax + Decitabine Improve Senior AML Patients’ Chances of Receiving a Transplant

NPM1 Mutation in AML: Prognosis, Testing, & Treatments image

NPM1 Mutation in AML: Prognosis, Testing, & Treatments

New Trial Required for Iomab-B FDA Approval image

New Trial Required for Iomab-B FDA Approval

FDA Grants Priority Review for Revumenib to Treat Relapsed or Refractory AML image

FDA Grants Priority Review for Revumenib to Treat Relapsed or Refractory AML

Load More

Core Education

What are FLT3 Inhibitors, and How are They Used in AML? image

What are FLT3 Inhibitors, and How are They Used in AML?

What is Pancytopenia? Symptoms, Causes, & Treatments image

What is Pancytopenia? Symptoms, Causes, & Treatments

What Are The AML Types, and How Are They Classified? image

What Are The AML Types, and How Are They Classified?

Does AML Go to the Brain? image

Does AML Go to the Brain?

What is Relapsed & Refractory AML? image

What is Relapsed & Refractory AML?

What Is The Difference Between Chronic And Acute Leukemia? image

What Is The Difference Between Chronic And Acute Leukemia?

Load More

Trending Articles

RVU120: A New Treatment in Clinical Trials for AML, MDS, and Myelofibrosis

AML: Donor Age, Not Just a Number

Acute Myeloid Leukemia and Your Kidneys: What You Need to Know

NPM1 Mutation in AML: Prognosis, Testing, & Treatments

Recruiting Trials for New Therapy Regimen for AML Patients

Patient Stories

articles for Patient Stories

James' Journey with AML: A Story of Resilience and Acceptance Meet AML Coach, Steve Hodges Meet AML Coach, Alan Katz

HealthTree Research

articles for HealthTree Research

Revolutionizing Blood Cancer Care: HealthTree Foundation's Commitment to Innovation Share HealthTree Cure Hub to Accelerate AML Research Participate in AML Research: Transportation Survey

Conferences

articles for Conferences

EHA 2024: Patient Outcomes from Oral Azacitidine Maintenance Therapy ASCO 2024: How Can Palliative Care Help AML Patients? ASCO 2024: How Effective is Prexigebersen for AML?

Clinical Trials

articles for Clinical Trials

Recruiting Trials for New Therapy Regimen for AML Patients RVU120: A New Treatment in Clinical Trials for AML, MDS, and Myelofibrosis CAR-T Therapy Trial for Relapsed/Refractory Acute Myeloid Leukemia

HealthTree Press

articles for HealthTree Press

HealthTree Foundation Featured on Fox News HealthTree Foundation Featured on ABC News HealthTree Foundation Announces Launch of HealthTree Research Hub in Multiple Myeloma

HealthTree Programs

articles for HealthTree Programs

The Future of Blood Cancer: Advances in Detection, Treatment, and Research AML and Fertility: Unlocking Knowledge with HealthTree University for AML How Can Patient Navigators Help Me Access Cancer Care?

Thanks to our HealthTree Community for Acute Myeloid Leukemia Sponsors:

Abbvie

Astellas Pharma

Servier

Follow Us

Charity Navigator

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2024 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811